Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
Tóm tắt
The chronic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are recognized as important causes of gastrointestinal disease in children and adults. In this review we delineate the clinical manifestations and diagnostic features of IBD. In addition, we summarize important recent advances in our understanding of the immune mediators of intestinal inflammation. This information has led to new therapeutic approaches in IBD. Further, we discuss the considerable data that point to the significance of genetic factors in the development of IBD and the genetic loci which have been implicated through genomewide searches. The commensal bacterial flora also appears to be a critical element, particularly in regards to Crohn's disease, although the precise role of the bacteria in the disease manifestations remains unclear. Current investigations promise to yield fresh insights in these areas.
Từ khóa
Tài liệu tham khảo
Andus, T., and V. Gross. 2000. Etiology and pathophysiology of inflammatory bowel disease—environmental factors. Hepatogastroenterology47:29–43.
Anonymous. 1998. WHO concludes that measles viruses are not associated with Crohn’s disease. Commun. Dis. Rep. Wkly.8:75–78.
Cartun, R. W., H. J. Van Kruiningen, C. A. Pedersen, M. M. Berman. 1993. An immunocytochemical search for infectious agents in Crohn’s disease. Mod. Pathol.6:212–219.
Dielman, L. A., A. S. Pena, S. G. M. Meuwissen, and E. P. Van Rees. 1997. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand. J. Gastroenterol.32(Suppl. 223):99–104.
Engstrand L. 1995. Mycobacterium paratuberculosis and Crohn’s disease. Scand. J. Infect. Dis. Suppl.98:27–29.
Fuss, I. J., M. Neurath, M. Bonrivant, et al. 1996. Disparate CD4+ T lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol.157:1261–1270.
Grand, R. J., J. Ramakrishna, and K. A. Calenda. 1996. Therapeutic strategies for pediatric Crohn’s disease. Clin. Investig. Med.19:373–380.
Hanauer, S. B. 1996. Inflammatory bowel disease, p. 705–715. In J. C. Bennett and F. Plum (ed.), Cecil textbook of medicine, 20th ed. The W. B. Saunders Co., Philadelphia, Pa.
Mayer, L., and H. Janowitz. 1988. Extraintestinal manifestations of inflammatory bowel disease, p.299–317. In J. B. Kirsner and E. G. Shorter (ed.), Inflammatory bowel disease. Lea & Febiger, Philadelphia, Pa.
Monbaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell75:274–282.
Monteleone, G., F. Trapasso, T. Parrello, L. Biancone, A. Stella, R. Iuliano, F. Luzza, A. Fusco, and F. Pallone. 1999. Bioactive IL-18 expression is up-regulated in Crohn’s disease. J. Immunol.163:143–147.
Onuma, E. K., P. S. Amenta, K. Ramaswamy, J. J. Lin, and K. M. Das. 2000. Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5. Clin. Exp. Immunol.121:466–471.
Orholm, M., V. Binder, T. I. A. Sorensen, and K. Kyvik. 1996. Inflammatory bowel disease in a Danish twin register. Gut39(Suppl. 3):A187.
Panwala, C. M., J. C. Jones, and J. L. Viney. 1998. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistant gene, mdr1a, spontaneously develop colitis. J. Immunol.161:5733–5744.
Pizarro, T. T., M. H. Michie, M. Bentz, J. Woraratanadharm, M. F. Smith, Jr., E. Foley, C. A. Moskaluk, S. J. Bickston, and F. Cominelli. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: expression and localization in intestinal mucosal cells. J. Immunol.162:6829–6835.
Subhani, J., S. M. Montgomery, R. E. Pounder, and A. J. Wakefield. 1998. Concordance rates of twins and siblings in inflammatory bowel disease (IBD). Gut42(Suppl. 1):A40.
Takeda, K., T. Kaisho, N. Terada, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity10:34–49.
Thomas, G. A. O., D. Millar-Jones, J. Rhodes, G. M. Roberts, G. T. Williams, and J. F. Mayberry. 1995. Incidence of Crohn’s disease in Cardiff over 60 years. 1986–1990. An update. Eur. J. Gastroenterol. Hepatol.7:401–405.
Turumen, U., M. Fakkila, V. Yaltonen, et al. 1993. Longterm outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn’s disease. Gastroenterology104:A793.
van Milligen de Wit, A. W., S. J. van Deventer, and G. N. Tytgat. 1995. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am. J. Gastroenterol.90:893–900.
Wakefield A. J., S. M. Montgomery, and R. E. Pounder. 1999. Crohn’s disease: the case for measles virus. Ital. J. Gastroenterol. Hepatol.31:247–254.
Wirtz S., S. Finotto, S. Kanzler, et al. 1999. Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transferr by TNF-plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. J. Immunol.162:1884–1888.